NCT05694559 Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
| NCT ID | NCT05694559 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-11-23 |
| Primary Completion | 2027-02-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2022-11-23 with a primary completion date of 2027-02-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To identify Black individuals who are eligible for genetic testing through trusted community organizations, and to connect Black individuals and their families to genetic testing and counseling so that they can know their cancer risk and how to decrease it.
Eligibility Criteria
Inclusion Criteria: * Any participant over 18 years old who self-identifies as Black or African-American and signs an informed consent form, also referred to as the 'Permission to Contact' form, to be part of our study. Exclusion Criteria: None
Contact & Investigator
Banu Arun, MD
PRINCIPAL INVESTIGATOR
MD Anderson Cancer Cneter
Frequently Asked Questions
Who can join the NCT05694559 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05694559 currently recruiting?
Yes, NCT05694559 is actively recruiting participants. Contact the research team at barun@mdanderson.org for enrollment information.
Where is the NCT05694559 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05694559 clinical trial?
NCT05694559 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Banu Arun, MD at MD Anderson Cancer Cneter. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.